Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defining privileged reagents using subsimilarity comparison.

Brett A Tounge1, Charles H Reynolds

  • 1Johnson & Johnson Pharmaceutical Research and Development, L.L.C., P.O. Box 776, Welsh and McKean Roads, Spring House, Pennsylvania 19477-0776, USA. btounge@prdus.jnj.com

Journal of Chemical Information and Computer Sciences
|September 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The New Paradigm in Pharma R&D.

ACS medicinal chemistry letters·2025
Same author

Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases.

Molecular cancer therapeutics·2025
Same author

Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease.

Neuron·2022
Same author

Chemistry, information and Frank: a tribute to Frank Brown.

Journal of computer-aided molecular design·2018
Same author

Inhibitor Bound Dengue NS2B-NS3pro Reveals Multiple Dynamic Binding Modes.

Biochemistry·2018
Same author

An improved set of mndo parameters for sulfur.

Journal of computational chemistry·2017

A new drug-likeness scoring method uses topological torsion (TT) 2D descriptors to evaluate reagent similarity to known compounds. This approach identifies novel reagents with improved drug-like properties compared to existing databases.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Assessing the drug-likeness of chemical reagents is crucial for efficient drug discovery.
  • Existing methods may not accurately capture the structural similarity of novel reagents to established drug scaffolds.

Purpose of the Study:

  • To develop and validate a novel algorithm for assigning drug-like scores to chemical reagents.
  • To utilize topological torsion (TT) 2D descriptors for calculating reagent subsimilarity to substructural elements.

Main Methods:

  • Developed a new algorithm employing topological torsion (TT) 2D descriptors.
  • Computed subsimilarity scores of reagents against substructural elements in the Comprehensive Medicinal Chemistry (CMC) database.
  • Scored a test set of reagents from the "Comprehensive Survey of Combinatorial Library Synthesis: 2000" (J. Comb. Chem.).

Related Experiment Videos

Main Results:

  • Demonstrated the algorithm's utility by scoring a diverse set of reagents.
  • Compared subsimilarity score distributions of J. Comb. Chem. R-groups against the ACD, revealing a shift towards higher scores.
  • Derived a molecular weight-independent subsimilarity scoring algorithm.

Conclusions:

  • The developed TT-based subsimilarity scoring method effectively assesses reagent drug-likeness.
  • Novel reagents from combinatorial libraries exhibit higher subsimilarity scores, indicating potential for drug discovery.
  • The refined scoring algorithm mitigates bias from molecular weight.